UncategorizedNew Releases from NCBI BookshelfComparative Effectiveness of Focused Ultrasound Therapy for Movement Disorders.Comparative Effectiveness of Focused Ultrasound Therapy for Movement Disorders. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfDupilumab for treating moderate to severe atopic dermatitis.Dupilumab for treating moderate to severe atopic dermatitis. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfAlectinib for untreated ALK-positive advanced non-small-cell lung cancer.Alectinib for untreated ALK-positive advanced non-small-cell lung cancer. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfOcrelizumab for treating relapsing–remitting multiple sclerosis.Ocrelizumab for treating relapsing–remitting multiple sclerosis. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfArsenic trioxide for treating acute promyelocytic leukaemia.Arsenic trioxide for treating acute promyelocytic leukaemia. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfBrentuximab vedotin for treating CD30-positive Hodgkin lymphoma.Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfGuselkumab for treating moderate to severe plaque psoriasis.Guselkumab for treating moderate to severe plaque psoriasis. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfMidostaurin for untreated acute myeloid leukaemia.Midostaurin for untreated acute myeloid leukaemia. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfAvelumab for treating metastatic Merkel cell carcinoma.Avelumab for treating metastatic Merkel cell carcinoma. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfCabozantinib for treating medullary thyroid cancer.Cabozantinib for treating medullary thyroid cancer. Leave a Comment / Uncategorized / admin Post Content